Welcome to our dedicated page for ROYCE MICRO-CAP TRUST SEC filings (Ticker: RMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ROYCE MICRO-CAP TRUST's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ROYCE MICRO-CAP TRUST's regulatory disclosures and financial reporting.
Saba Capital Management, L.P., Saba Capital Management GP, LLC and Boaz R. Weinstein filed Amendment No. 1 to a Schedule 13D reporting beneficial ownership of 3,252,976 Royce Micro-Cap Trust, Inc. common shares, representing 6.08% of the outstanding shares based on 53,478,521 shares outstanding as of December 31, 2025.
The reporting persons hold only shared voting and dispositive power over these shares and state that approximately $32,550,536 was paid to acquire them, funded by investor subscription proceeds, capital appreciation and ordinary-course margin borrowings. Recent transactions over the 60 days prior to June 24, 2026 were executed in the open market as described in an attached schedule.
ROYCE MICRO-CAP TRUST, INC. president Christopher D. Clark made an open-market purchase of 3,600 shares of Common Stock at $14.12 per share. This transaction increases his direct holdings to 73,319 shares, signaling a modest addition to his personal stake in the fund.
ROYCE MICRO-CAP TRUST, INC. Secretary John E. Denneen reported an open-market purchase of 4,000 shares of Common Stock at a price of $13.70 per share. Following this transaction, he directly owns 12,232 shares of the company’s common stock.
ROYCE MICRO-CAP TRUST, INC. secretary John E. Denneen made an open-market purchase of 3,249 shares of Common Stock at $13.97 per share. After this transaction, he directly holds a total of 8,232 shares, indicating a modest increase in his personal stake.
ROYCE MICRO-CAP TRUST, INC. president and director Christopher D. Clark made an open-market purchase of 6,500 shares of the company’s common stock. The shares were bought at a price of $11.48 per share. Following this transaction, his directly owned stake increased to 68,648 common shares.
Royce Micro-Cap Trust, Inc. reported that President and director Christopher D. Clark made an open-market purchase of 6,500 shares of the company’s Common Stock at a price of $11.48 per share. Following this transaction, he directly holds 68,648 shares of Common Stock.
RMT submitted a Form N-CEN annual report for a registered investment company, providing fund-level operational disclosures required by the Investment Company Act of 1940.
The filing lists aggregate brokerage commissions paid of $1,198,186.46 during the reporting period and identifies principal transactions with a largest reported dealer turnover of $2,814,934,123.59.
Royce Micro-Cap Trust, Inc. files its 2025 Certified Shareholder Report and 2025 Annual Review covering January 1, 2025–December 31, 2025. The report includes the Funds’ annual review, performance tables, schedules of investments, financial statements, and management discussion.
Royce Micro-Cap Trust advanced 16.6% on a net asset value basis in 2025 versus the Russell 2000’s 12.8%. The report notes portfolio positioning, sector contributors and detractors, Fund diagnostics (net assets of $631 million, NAV $11.79, market price $10.43, turnover 41%), and the Fund’s managed distribution policy described earlier in the materials.
Saba Capital Management and affiliates have disclosed a significant position in Royce Micro-Cap Trust, Inc. The group, including Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein, reports beneficial ownership of 2,628,462 common shares, representing 5% of the outstanding stock, based on 52,592,863 shares outstanding as of 8/5/25. They state that about $26,301,407 was paid to acquire these shares, using investor subscription proceeds, related appreciation, and ordinary-course margin borrowings.
The filing says the shares were acquired in the ordinary course for investment because they believe the stock is undervalued. The reporting persons may engage with management, the board, and other shareholders on topics such as operations, governance, board appointments, capitalization, trading at a discount to net asset value, and the open or closed end nature and potential liquidation timing of the trust. They may consider actions including proxy solicitation, shareholder proposals, or board nominations, and may increase, reduce, or hedge their position over time.
Royce Micro-Cap Trust, Inc. (RMT) insider filed a Form 4 reporting a sale of common stock. On 11/05/2025, the reporting person executed a Code S transaction, disposing of 200,000 shares at a price of $10.27 per share.
Following the reported transaction, the filing shows 596,926 shares beneficially owned directly. It also lists indirect holdings of 457,070 shares held in the Royce Charitable Trust and 26,074 shares held through a family investment entity. A footnote states the reporting person is the sole managing member of the family investment entity and disclaims beneficial ownership of portions in which there is no pecuniary interest.
The relationship to the issuer is marked as “Other” with the title Sr. Advisor Royce & Associates.